{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:37:14Z","timestamp":1791463034823,"version":"4.3.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.eprac.2023.12.004","type":"journal-article","created":{"date-parts":[[2023,12,10]],"date-time":"2023-12-10T10:37:46Z","timestamp":1702204666000},"page":"231-238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The Ca\u2217Cl\/P Ratio: A Novel and More Appropriate Screening Tool for Normocalcaemic or Overt Primary Hyperparathyroidism"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-3320-2124","authenticated-orcid":false,"given":"Yanling","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengning","family":"Chuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengping","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4067-7126","authenticated-orcid":false,"given":"Bo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.eprac.2023.12.004_bib1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.beem.2018.09.004","article-title":"Primary hyperparathyroidism","volume":"32","author":"Silva","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"issue":"3","key":"10.1016\/j.eprac.2023.12.004_bib2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/cen.12569","article-title":"Characteristics of hyperparathyroid states in the Canadian multicentre osteoporosis study (CaMos) and relationship to skeletal markers","volume":"82","author":"Berger","year":"2015","journal-title":"Clin Endocrinol"},{"issue":"1","key":"10.1016\/j.eprac.2023.12.004_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00198-016-3716-2","article-title":"Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus","volume":"28","author":"Khan","year":"2017","journal-title":"Osteoporos Int"},{"issue":"10","key":"10.1016\/j.eprac.2023.12.004_bib4","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","article-title":"The American association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism","volume":"151","author":"Wilhelm","year":"2016","journal-title":"JAMA Surgery"},{"key":"10.1016\/j.eprac.2023.12.004_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2014.12.003","article-title":"Secular trends in the incidence of primary hyperparathyroidism over five decades (1965-2010)","volume":"73","author":"Griebeler","year":"2015","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.eprac.2023.12.004_bib6","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1210\/jc.2014-1414","article-title":"Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the fourth international Workshop","volume":"99","author":"Eastell","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.eprac.2023.12.004_bib7","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1210\/jc.2014-1415","article-title":"Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the fourth international Workshop","volume":"99","author":"Silverberg","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.eprac.2023.12.004_bib8","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.beem.2018.09.009","article-title":"Management of normocalcemic primary hyperparathyroidism","volume":"32","author":"Cusano","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"issue":"2","key":"10.1016\/j.eprac.2023.12.004_bib9","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s12020-012-9627-x","article-title":"Investigation of insulin resistance in patients with normocalcemic primary hyperparathyroidism","volume":"42","author":"Cakir","year":"2012","journal-title":"Endocrine"},{"issue":"13","key":"10.1016\/j.eprac.2023.12.004_bib10","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.3346\/jkms.2022.37.e99","article-title":"Comparisons between normocalcemic primary hyperparathyroidism and typical primary hyperparathyroidism","volume":"37","author":"Choi","year":"2022","journal-title":"J\u00a0Kor Med Sci"},{"issue":"8","key":"10.1016\/j.eprac.2023.12.004_bib11","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1210\/jc.2006-2802","article-title":"Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype","volume":"92","author":"Lowe","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2023.12.004_bib12","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1590\/S0004-27302011000500003","article-title":"Normocalcemic primary hyperparathyroidism in clinical practice: an indolent condition or a silent threat?","volume":"55","author":"Marques","year":"2011","journal-title":"Arq Bras Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2023.12.004_bib13","first-page":"294","article-title":"Primary hyperparathyroidism, with A focus on management of the normocalcemic form: to treat or not to treat? Endocrine practice","volume":"22","author":"\u0160iprov\u00e1","year":"2016"},{"issue":"2","key":"10.1016\/j.eprac.2023.12.004_bib15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/jbm4.10019","article-title":"Serum calcium to phosphorous (Ca\/P) ratio is a simple, inexpensive, and accurate tool in the diagnosis of primary hyperparathyroidism","volume":"2","author":"Madeo","year":"2017","journal-title":"JBMR Plus"},{"issue":"8","key":"10.1016\/j.eprac.2023.12.004_bib16","first-page":"801","article-title":"Performance of chloride\/phosphate test in patients with primary hyperparathyroidism. Is it related to calcium level?","volume":"34","author":"Mismar","year":"2013","journal-title":"Saudi Med J"},{"issue":"25","key":"10.1016\/j.eprac.2023.12.004_bib17","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMcp1106636","article-title":"Clinical practice. Primary hyperparathyroidism","volume":"365","author":"Marcocci","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.eprac.2023.12.004_bib18","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/MED.0000000000000198","article-title":"An overview of normocalcemic primary hyperparathyroidism","volume":"22","author":"Pawlowska","year":"2015","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"11","key":"10.1016\/j.eprac.2023.12.004_bib19","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1530\/EC-21-0267","article-title":"Diagnostic performance of the calcium\/phosphate ratio for primary hyperparathyroidism in southwest China","volume":"10","author":"Yin","year":"2021","journal-title":"Endocrine Connections"},{"issue":"4","key":"10.1016\/j.eprac.2023.12.004_bib20","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1007\/s00268-018-4512-2","article-title":"Classic primary hyperparathyroidism versus normocalcemic and normohormonal variants: do they really differ?","volume":"42","author":"Kiriakopoulos","year":"2018","journal-title":"World J Surg"},{"issue":"7","key":"10.1016\/j.eprac.2023.12.004_bib21","doi-asserted-by":"crossref","first-page":"e2609","DOI":"10.1210\/clinem\/dgaa174","article-title":"Clinical, biochemical, and radiological profile of normocalcemic primary hyperparathyroidism","volume":"105","author":"Palermo","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2023.12.004_bib22","doi-asserted-by":"crossref","first-page":"908","DOI":"10.2214\/AJR.07.3160","article-title":"Primary hyperparathyroidism: is there an increased prevalence of renal stone disease?","volume":"191","author":"Suh","year":"2008","journal-title":"Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.eprac.2023.12.004_bib23","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.1038\/s41598-017-05183-6","article-title":"The chloride\/phosphate ratio combined with alkaline phosphatase as a valuable predictive marker for primary hyperparathyroidism in Chinese individuals","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.eprac.2023.12.004_bib24","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ecl.2018.07.003","article-title":"Physiology of parathyroid hormone","volume":"47","author":"Goltzman","year":"2018","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"2","key":"10.1016\/j.eprac.2023.12.004_bib25","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7326\/0003-4819-80-2-200","article-title":"The chloride-phosphate ratio in hypercalcemia","volume":"80","author":"Palmer","year":"1974","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.eprac.2023.12.004_bib26","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/0194599820947009","article-title":"The utility of the Cl:PO4 ratio in patients with variant versions of primary hyperparathyroidism","volume":"164","author":"Wright","year":"2021","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"1","key":"10.1016\/j.eprac.2023.12.004_bib27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1530\/eje.1.02173","article-title":"Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screening","volume":"155","author":"Hagstr\u00f6m","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.eprac.2023.12.004_bib28","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0039-6060(97)90357-3","article-title":"Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women","volume":"121","author":"Lundgren","year":"1997","journal-title":"Surgery"},{"key":"10.1016\/j.eprac.2023.12.004_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1203437","article-title":"The Russian registry of primary hyperparathyroidism, latest update","volume":"14","author":"Mokrysheva","year":"2023","journal-title":"Front Endocrinol"},{"issue":"4","key":"10.1016\/j.eprac.2023.12.004_bib30","doi-asserted-by":"crossref","first-page":"e1171","DOI":"10.1210\/clinem\/dgaa084","article-title":"Normocalcemic hyperparathyroidism: study of its prevalence and natural history","volume":"105","author":"Schini","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.eprac.2023.12.004_bib31","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/humupd\/dmq008","article-title":"Bone fractures after menopause","volume":"16","year":"2010","journal-title":"Hum Reprod Update"},{"issue":"4","key":"10.1016\/j.eprac.2023.12.004_bib32","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/ajcn\/80.4.998","article-title":"Effect of age on calcium absorption in postmenopausal women","volume":"80","author":"Nordin","year":"2004","journal-title":"Am J Clin Nutr"},{"issue":"10","key":"10.1016\/j.eprac.2023.12.004_bib33","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1359\/jbmr.2003.18.10.1725","article-title":"Intestinal calcium transporter genes are upregulated by estrogens and the reproductive cycle through vitamin D receptor-independent mechanisms","volume":"18","author":"Van Cromphaut","year":"2003","journal-title":"J\u00a0Bone Miner Res"},{"issue":"2","key":"10.1016\/j.eprac.2023.12.004_bib34","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.bone.2010.05.002","article-title":"Age but not gender modulates the relationship between PTH and vitamin D","volume":"47","author":"Arabi","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.eprac.2023.12.004_bib35","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1007\/s40618-023-02107-2","article-title":"Big data-based parathyroid hormone (PTH) values emphasize need for age correction","volume":"46","author":"Cavalcante","year":"2023","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"3","key":"10.1016\/j.eprac.2023.12.004_bib36","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1530\/EJE-15-0595","article-title":"Serum PTH reference values established by an automated third-generation assay in vitamin D-replete subjects with normal renal function: consequences of diagnosing primary hyperparathyroidism and the classification of dialysis patients","volume":"174","author":"Souberbielle","year":"2016","journal-title":"Eur J Endocrinol"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X23007814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X23007814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:16:31Z","timestamp":1761516991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X23007814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1530891X23007814"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2023.12.004","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Ca\u2217Cl\/P Ratio: A Novel and More Appropriate Screening Tool for Normocalcaemic or Overt Primary Hyperparathyroidism","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2023.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 AACE. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}